Review
Published on 08 Sep 2023
Application of cell-derived exosomes in the hematological malignancies therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1263834
- 2,623 views
- 4 citations
Type at least 3 characters
2,601 articles
Articles
Correction
Published on 08 Sep 2023
Corrigendum: Paraptosis: a unique cell death mode for targeting cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1274076
- 1,411 views
- 2 citations
Editorial
Published on 08 Sep 2023
Editorial: Translating nanomedicines for anti-cancer treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1236981
- 1,227 views
- 1 citation
Original Research
Published on 07 Sep 2023
Analyzing the research landscape: Mapping frontiers and hot spots in anti-cancer research using bibliometric analysis and research network pharmacology
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1256188
- 3,188 views
- 12 citations
Systematic Review
Published on 07 Sep 2023
Comparative safety of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1223929
- 4,272 views
- 7 citations
Original Research
Published on 07 Sep 2023
A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1236655
- 2,423 views
- 2 citations
Original Research
Published on 06 Sep 2023
A pH-responsive bi-MIL-88B MOF coated with folic acid-conjugated chitosan as a promising nanocarrier for targeted drug delivery of 5-Fluorouracil
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1265440
- 3,980 views
- 13 citations
Original Research
Published on 06 Sep 2023
CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1257289
- 4,703 views
- 1 citation
Correction
Published on 05 Sep 2023
Corrigendum: Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1285522
- 1,463 views
Original Research
Published on 05 Sep 2023
Maltol has anti-cancer effects via modulating PD-L1 signaling pathway in B16F10 cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1255586
- 2,844 views
- 4 citations
Original Research
Published on 05 Sep 2023
Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1234342
- 2,386 views
- 3 citations
Original Research
Published on 05 Sep 2023
Bioinformatics analysis and identification of upregulated tumor suppressor genes associated with suppressing colon cancer progression by curcumin treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1218046
- 2,470 views
- 1 citation
Review
Published on 01 Sep 2023
Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1189799
- 2,715 views
- 4 citations
Original Research
Published on 01 Sep 2023
Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on breast carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1135898
- 5,511 views
- 13 citations
Original Research
Published on 31 Aug 2023
Artesunate, as an Hsp90 inhibitor, inhibits the proliferation of Burkitt’s lymphoma cells by inhibiting AKT and ERK
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1218467
- 1,956 views
- 4 citations
Original Research
Published on 31 Aug 2023
Metabolic-suppressed cancer-associated fibroblasts limit the immune environment and survival in colorectal cancer with liver metastasis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1212420
- 2,925 views
- 1 citation